QQQ   352.26 (+1.23%)
AAPL   179.98 (+1.54%)
MSFT   331.96 (+1.09%)
META   273.40 (+3.28%)
GOOGL   123.48 (+0.50%)
AMZN   123.28 (+2.24%)
TSLA   208.38 (+2.18%)
NVDA   398.85 (+5.42%)
NIO   7.59 (+0.80%)
BABA   83.74 (+5.27%)
AMD   120.31 (+1.78%)
T   15.80 (+0.45%)
F   12.12 (+1.00%)
MU   69.24 (+1.52%)
CGC   0.83 (-0.61%)
GE   104.97 (+3.39%)
DIS   88.62 (+0.75%)
AMC   4.61 (+2.44%)
PFE   38.02 (+0.00%)
PYPL   63.16 (+1.89%)
NFLX   404.18 (+2.26%)
QQQ   352.26 (+1.23%)
AAPL   179.98 (+1.54%)
MSFT   331.96 (+1.09%)
META   273.40 (+3.28%)
GOOGL   123.48 (+0.50%)
AMZN   123.28 (+2.24%)
TSLA   208.38 (+2.18%)
NVDA   398.85 (+5.42%)
NIO   7.59 (+0.80%)
BABA   83.74 (+5.27%)
AMD   120.31 (+1.78%)
T   15.80 (+0.45%)
F   12.12 (+1.00%)
MU   69.24 (+1.52%)
CGC   0.83 (-0.61%)
GE   104.97 (+3.39%)
DIS   88.62 (+0.75%)
AMC   4.61 (+2.44%)
PFE   38.02 (+0.00%)
PYPL   63.16 (+1.89%)
NFLX   404.18 (+2.26%)
QQQ   352.26 (+1.23%)
AAPL   179.98 (+1.54%)
MSFT   331.96 (+1.09%)
META   273.40 (+3.28%)
GOOGL   123.48 (+0.50%)
AMZN   123.28 (+2.24%)
TSLA   208.38 (+2.18%)
NVDA   398.85 (+5.42%)
NIO   7.59 (+0.80%)
BABA   83.74 (+5.27%)
AMD   120.31 (+1.78%)
T   15.80 (+0.45%)
F   12.12 (+1.00%)
MU   69.24 (+1.52%)
CGC   0.83 (-0.61%)
GE   104.97 (+3.39%)
DIS   88.62 (+0.75%)
AMC   4.61 (+2.44%)
PFE   38.02 (+0.00%)
PYPL   63.16 (+1.89%)
NFLX   404.18 (+2.26%)
QQQ   352.26 (+1.23%)
AAPL   179.98 (+1.54%)
MSFT   331.96 (+1.09%)
META   273.40 (+3.28%)
GOOGL   123.48 (+0.50%)
AMZN   123.28 (+2.24%)
TSLA   208.38 (+2.18%)
NVDA   398.85 (+5.42%)
NIO   7.59 (+0.80%)
BABA   83.74 (+5.27%)
AMD   120.31 (+1.78%)
T   15.80 (+0.45%)
F   12.12 (+1.00%)
MU   69.24 (+1.52%)
CGC   0.83 (-0.61%)
GE   104.97 (+3.39%)
DIS   88.62 (+0.75%)
AMC   4.61 (+2.44%)
PFE   38.02 (+0.00%)
PYPL   63.16 (+1.89%)
NFLX   404.18 (+2.26%)
NASDAQ:DBVT

DBV Technologies (DBVT) Stock Forecast, Price & News

$1.96
+0.02 (+0.77%)
(As of 02:32 PM ET)
Compare
Today's Range
$1.91
$2.00
50-Day Range
$1.42
$2.23
52-Week Range
$1.08
$3.43
Volume
50,847 shs
Average Volume
92,792 shs
Market Capitalization
$369.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.67

DBV Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
245.4% Upside
$6.67 Price Target
Short Interest
Bearish
0.91% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of DBV Technologies in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.51) to ($0.47) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.41 out of 5 stars

Medical Sector

1877th out of 1,980 stocks

Biological Products, Except Diagnostic Industry

313th out of 330 stocks


DBVT stock logo

About DBV Technologies (NASDAQ:DBVT) Stock

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.

Receive DBVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DBV Technologies and its competitors with MarketBeat's FREE daily newsletter.

DBVT Stock News Headlines

AI Getting Close to Thinking Like Humans
Technology experts working with neuroscientists have created the world's first Artificial Intelligence Network Operating System. AI can now process information like the human brain and understand the world the way humans do.
ChatGPT Is Already "Old School"
As good as ChatGPT is at writing content, it still doesn't understand what it's saying. But a new AI technology breakthrough will understand and process information like a human. One young company is leading the way.
DBV Technologies Update
See More Headlines

DBVT Price History

DBVT Company Calendar

Last Earnings
5/04/2023
Today
6/01/2023
Next Earnings (Estimated)
8/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DBVT
Employees
92
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.67
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+241.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
$-96,270,000.00
Net Margins
-778.60%
Pretax Margin
-2,228.93%

Debt

Sales & Book Value

Annual Sales
$4.84 million
Book Value
$0.95 per share

Miscellaneous

Free Float
187,144,000
Market Cap
$367.13 million
Optionable
Optionable
Beta
1.27

Key Executives

  • Daniel Tassé
    Chief Executive Officer & Executive Director
  • Sébastien Robitaille
    Chief Financial Officer
  • Pharis Mohideen
    Chief Medical Officer
  • Pascal Wotling
    Chief Technical Operations & Quality Officer
  • Pascale Ehouarn
    Chief Engineering, Manufacturing & Supply Officer













DBVT Stock - Frequently Asked Questions

Should I buy or sell DBV Technologies stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DBV Technologies in the last twelve months. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DBVT shares.
View DBVT analyst ratings
or view top-rated stocks.

What is DBV Technologies' stock price forecast for 2023?

5 brokers have issued 1-year price objectives for DBV Technologies' stock. Their DBVT share price forecasts range from $4.00 to $10.00. On average, they predict the company's stock price to reach $6.67 in the next twelve months. This suggests a possible upside of 241.9% from the stock's current price.
View analysts price targets for DBVT
or view top-rated stocks among Wall Street analysts.

How have DBVT shares performed in 2023?

DBV Technologies' stock was trading at $1.53 at the beginning of 2023. Since then, DBVT stock has increased by 27.5% and is now trading at $1.95.
View the best growth stocks for 2023 here
.

When is DBV Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 7th 2023.
View our DBVT earnings forecast
.

How were DBV Technologies' earnings last quarter?

DBV Technologies S.A. (NASDAQ:DBVT) issued its quarterly earnings results on Thursday, May, 4th. The company reported ($0.11) EPS for the quarter, beating analysts' consensus estimates of ($0.25) by $0.14. The company earned $2.19 million during the quarter, compared to analyst estimates of $1.30 million. DBV Technologies had a negative net margin of 778.60% and a negative trailing twelve-month return on equity of 48.25%.

What other stocks do shareholders of DBV Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DBV Technologies investors own include Aimmune Therapeutics (AIMT), OPKO Health (OPK), Bellicum Pharmaceuticals (BLCM), Axsome Therapeutics (AXSM), Gilead Sciences (GILD), Novavax (NVAX), AbbVie (ABBV), Pieris Pharmaceuticals (PIRS), Pfizer (PFE) and Sangamo Therapeutics (SGMO).

What is DBV Technologies' stock symbol?

DBV Technologies trades on the NASDAQ under the ticker symbol "DBVT."

Who are DBV Technologies' major shareholders?

DBV Technologies' stock is owned by a number of retail and institutional investors. Top institutional investors include Ameriprise Financial Inc. (0.64%), BlackRock Inc. (0.52%) and OLD Mission Capital LLC (0.02%).

How do I buy shares of DBV Technologies?

Shares of DBVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DBV Technologies' stock price today?

One share of DBVT stock can currently be purchased for approximately $1.95.

How much money does DBV Technologies make?

DBV Technologies (NASDAQ:DBVT) has a market capitalization of $367.13 million and generates $4.84 million in revenue each year. The company earns $-96,270,000.00 in net income (profit) each year or ($0.61) on an earnings per share basis.

How can I contact DBV Technologies?

DBV Technologies' mailing address is 177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE I0, 92120. The official website for the company is www.dbv-technologies.com. The company can be reached via phone at (315) 542-7878, via email at sara.sherman@dbv-technologies.com, or via fax at 33-1-43-26-10-83.

This page (NASDAQ:DBVT) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -